Objective:

To introduce and explain the capabilities of mcPCR in enhancing molecular pathology, particularly in detecting methylation patterns relevant to cancer and chronic diseases.

Key Findings:

• Standard PCR fails to capture methylation patterns, losing critical epigenetic signals.
• mcPCR uses a methyltransferase step to preserve and amplify methylation alongside DNA sequences, enhancing sensitivity for low-input samples.
• mcPCR can enhance the sensitivity of methylation-based assays for cancer and chronic diseases, allowing for earlier detection.

Interpretation:

mcPCR represents a significant advancement in molecular diagnostics, potentially improving early detection and monitoring of diseases through enhanced analysis of methylation patterns.

Limitations:

• Challenges in ensuring high-throughput and non-destructive workflows, particularly for small biopsies.
• Need for reliable performance on low-input and non-invasive samples, such as blood or saliva.

Conclusion:

mcPCR could revolutionize disease detection and monitoring, allowing for earlier interventions and improved patient management through non-invasive methods, potentially leading to better treatment outcomes.